Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
about
Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus IsolatesTreatment of Gram-positive infections in critically ill patientsTeicoplanin as an effective alternative to vancomycin for treatment of MRSA infection in Chinese population: a meta-analysis of randomized controlled trials.Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus.Identification of gene clusters associated with host adaptation and antibiotic resistance in Chinese Staphylococcus aureus isolates by microarray-based comparative genomics.Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China.Predicting risk for death from MRSA bacteremia.Comparative proteomics-based identification of genes associated with glycopeptide resistance in clinically derived heterogeneous vancomycin-intermediate Staphylococcus aureus strains.Heterogeneous vancomycin resistance in Staphylococcus aureus: a review of epidemiology, diagnosis, and clinical significance.Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolatesCurrent and prospective treatments for multidrug-resistant gram-positive infections.Antimicrobial heteroresistance: an emerging field in need of clarity.Decreased Vancomycin MICs among Methicillin-Resistant Staphylococcus aureus Clinical Isolates at a Chinese Tertiary Hospital over a 12-year Period.VanA-Type MRSA (VRSA) Emerged in Surface Waters.Methicillin-Resistant Staphylococcus aureus Grown on Vancomycin-Supplemented Screening Agar Displays Enhanced Biofilm Formation.First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia.Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.Performance of various testing methodologies for detection of heteroresistant vancomycin-intermediate Staphylococcus aureus in bloodstream isolates.Distribution of the Most Prevalent Spa Types among Clinical Isolates of Methicillin-Resistant and -Susceptible Staphylococcus aureus around the World: A Review.Phenotypic and molecular characterisation of Staphylococcus aureus with reduced vancomycin susceptibility derivated in vitro
P2860
Q26796560-76E808B2-1A8C-41F5-918A-A4D523A5E812Q27015976-D67FD3FD-6FFB-4C4D-B21B-6094C7251EE4Q31144203-EC0E0AC1-371A-4060-9438-B2EBC55BDA96Q34108614-3FE745D3-7006-4648-BFDD-C3AD0E8D1B74Q34544939-DFBECD9E-2DB1-4D4E-AC93-8BD371A4B149Q34998629-0738CF38-7260-4E4A-99FB-2E865113AA8CQ36037687-34F18A53-B0C5-4F41-B922-1492EED0CAE8Q36964857-CEC9E197-FC82-4F99-A266-1AF21053C795Q37717901-D41B8E3C-B56B-413E-9399-7445549E7E7BQ37809666-A2D4DEEF-4875-496F-B3EA-135BDD977887Q38123255-0ACF6CF7-5569-454B-A4A1-471D7E946AF0Q38310639-9A715794-2F7D-4348-BB74-4C7262E85D0FQ40456843-2B7A5317-EE9D-4B3E-B993-EA600339944EQ40662698-FDDBFB3D-FC23-40E0-9C40-9BF53EA7BC36Q40955966-0F8D1A66-A731-4A26-8C12-E2832E35C488Q41016957-11CB7150-65EB-4CB2-9B0D-A41441B1584AQ41711192-4ED8E6C8-3072-4DE3-AB74-82BA844FFECBQ41877894-92195529-A303-42CB-8418-ED1072CED520Q50327973-616D56EA-BFB1-4E33-83D3-DDF6B359647CQ58691028-32B24F37-6DC6-4ED2-A269-06E1D40DF975
P2860
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevalence and characterizatio ...... lates from 14 cities in China.
@en
Prevalence and characterizatio ...... lates from 14 cities in China.
@nl
type
label
Prevalence and characterizatio ...... lates from 14 cities in China.
@en
Prevalence and characterizatio ...... lates from 14 cities in China.
@nl
prefLabel
Prevalence and characterizatio ...... lates from 14 cities in China.
@en
Prevalence and characterizatio ...... lates from 14 cities in China.
@nl
P2093
P2860
P356
P1476
Prevalence and characterizatio ...... olates from 14 cities in China
@en
P2093
Chunjiang Zhao
Jianzhong Zhang
Minjun Chen
Wenjia Sun
Wright W Nichols
P2860
P304
P356
10.1128/AAC.00206-09
P407
P577
2009-06-22T00:00:00Z